These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36930146)

  • 21. Type 1 diabetes technology management traps in a pediatric patient: not all that glitters is gold.
    Piccini B; Casalini E; Macucci C; Toni S
    Acta Diabetol; 2022 Jan; 59(1):137-141. PubMed ID: 34417888
    [No Abstract]   [Full Text] [Related]  

  • 22. Where Do We Stand with Closed-Loop Systems and Their Challenges?
    Jackson M; Castle JR
    Diabetes Technol Ther; 2020 Jul; 22(7):485-491. PubMed ID: 32069100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter to the Editor Regarding Cost-Effectiveness of Hybrid Closed-Loop Systems Versus Multiple Daily Injections Plus Intermittently-Scanned Continuous Glucose Monitoring in Type 1 Diabetes in the Netherlands.
    Levrat-Guillen F; De Cock P
    Adv Ther; 2023 May; 40(5):2542-2544. PubMed ID: 36892808
    [No Abstract]   [Full Text] [Related]  

  • 24. Case series of a hybrid closed-loop system used in pregnancies in clinical practice.
    Polsky S; Akturk HK
    Diabetes Metab Res Rev; 2020 Mar; 36(3):e3248. PubMed ID: 31758630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin pump therapy and glucose control during Ramadan fasting in an adolescent with type 1 diabetes: from an open-loop sensor-augmented pump therapy with predictive low-glucose management to an advanced hybrid closed-loop system.
    Wannes S; Al Qusayer D; El Abed S; Ben Fredj M
    Acta Diabetol; 2023 Jun; 60(6):851-855. PubMed ID: 36811739
    [No Abstract]   [Full Text] [Related]  

  • 26. Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus.
    Lason I; Cyganek K; Witek P; Matejko B; Malecki MT; Skupien J
    Ginekol Pol; 2021; 92(10):675-681. PubMed ID: 33914316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First Randomized Controlled Trial of Hybrid Closed Loop Versus Multiple Daily Injections or Insulin Pump Using Self-Monitoring of Blood Glucose in Free-Living Adults with Type 1 Diabetes Undertaking Exercise.
    Paldus B; Lee MH; Morrison D; Zaharieva DP; Jones H; Obeyesekere V; Lu J; Vogrin S; LaGerche A; McAuley SA; MacIsaac RJ; Jenkins AJ; Ward GM; Colman P; O'Neal DN
    J Diabetes Sci Technol; 2021 Nov; 15(6):1399-1401. PubMed ID: 34315271
    [No Abstract]   [Full Text] [Related]  

  • 28. Review of the Omnipod
    Cobry EC; Berget C; Messer LH; Forlenza GP
    Ther Deliv; 2020 Aug; 11(8):507-519. PubMed ID: 32723002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm.
    Messer LH; Berget C; Forlenza GP
    Diabetes Technol Ther; 2019 Aug; 21(8):462-469. PubMed ID: 31140878
    [No Abstract]   [Full Text] [Related]  

  • 30. A retrospective analysis of 24-month real-world glucose control for children and adolescents with type 1 diabetes using the MiniMed™ 670G insulin pump.
    Delvecchio M; Galati A; Maffeis C; Passanisi S; Bonfanti R; Franceschi R; Tornese G; Calzi E; Zanfardino A; Bracciolini GP; Piccinno E;
    Diabetes Obes Metab; 2023 Apr; 25(4):1101-1105. PubMed ID: 36507706
    [No Abstract]   [Full Text] [Related]  

  • 31. A Mobile Application Guiding Patients With Type 1 Diabetes Using Sensor-Augmented Insulin Pump Therapy.
    Esvant A; Lefebvre MA; Campillo-Gimenez B; Lannes M; Delamarre D; Guilhem I; Poirier JY
    J Diabetes Sci Technol; 2016 Jul; 10(4):985-6. PubMed ID: 26902791
    [No Abstract]   [Full Text] [Related]  

  • 32. Glucose variability as the risk factor of preeclampsia in pregnant patients with type 1 diabetes mellitus.
    Tiselko AV; Kapustin RV; Milyutina YP; Borovik NV; Abashova EI; Yarmolinskaya MI
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9639-9646. PubMed ID: 35264056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
    Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Training and Support for Hybrid Closed-Loop Therapy.
    Boughton CK; Hartnell S; Allen JM; Fuchs J; Hovorka R
    J Diabetes Sci Technol; 2022 Jan; 16(1):218-223. PubMed ID: 32914648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in Device Uptake and Glycemic Control Among Pregnant Women With Type 1 Diabetes: Data From the T1D Exchange.
    Levy CJ; Foster NC; DuBose SN; Agarwal S; Lyons SK; Peters AL; Uwaifo GI; DiMeglio LA; Sherr JL; Polsky S
    J Diabetes Sci Technol; 2021 Nov; 15(6):1297-1302. PubMed ID: 33218278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
    Bergenstal RM; Garg S; Weinzimer SA; Buckingham BA; Bode BW; Tamborlane WV; Kaufman FR
    JAMA; 2016 Oct; 316(13):1407-1408. PubMed ID: 27629148
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes.
    Welsh JB
    Diabetes Technol Ther; 2018 Jun; 20(S2):S242-S249. PubMed ID: 29916736
    [No Abstract]   [Full Text] [Related]  

  • 39. Diabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D Exchange.
    Polsky S; Wu M; Bode BW; DuBose SN; Goland RS; Maahs DM; Foster NC; Peters AL; Levy CJ; Shah VN; Beck RW
    Diabetes Technol Ther; 2018 Aug; 20(8):517-523. PubMed ID: 29990438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expert Guidance on Off-Label Use of Hybrid Closed-Loop Therapy in Pregnancies Complicated by Diabetes.
    Szmuilowicz ED; Levy CJ; Buschur EO; Polsky S
    Diabetes Technol Ther; 2023 May; 25(5):363-373. PubMed ID: 36724300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.